
Oncologist

No OPD information available
Endometrial Cancer
Cervical Cancer
Ovarian Cancer
Ascites
Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)
Adult Soft Tissue Sarcoma
Agranulocytosis
Anal Cancer
Breast Cancer
Cerebral Hypoxia
Cervical Dysplasia
Familial Prostate Cancer
Febrile Neutropenia
Hysterectomy
Mesothelioma
Prostate Cancer
Retinoblastoma
Severe Acute Respiratory Syndrome (SARS)
Small Cell Lung Cancer (SCLC)
Turcot Syndrome
Vulvar Cancer
Linda R. Mileshkin is a female medical professional who helps people with different types of cancer like endometrial, cervical, ovarian, lung, and breast cancer. She also treats conditions such as ascites, agranulocytosis, and cerebral hypoxia. Linda has special skills in treating these diseases and uses advanced treatments to help her patients feel better.
Patients trust Linda because she communicates well with them, explaining things in a way they can understand. She listens to their concerns and works with them to create a treatment plan that suits their needs. Linda stays updated with the latest medical knowledge and research by reading scientific papers and attending conferences. This helps her provide the best care possible to her patients.
Linda works closely with other medical professionals, collaborating on treatment plans and sharing knowledge to ensure the best outcomes for patients. She values teamwork and believes that working together leads to better results for everyone involved. Linda's dedication to her patients and her colleagues has made a positive impact on many lives.
One of Linda's notable publications is a study on a new treatment for endometrial cancer, which shows her commitment to advancing medical knowledge. She has also been involved in clinical trials to test new treatments for cervical cancer. Linda's research contributes to improving cancer care and finding better ways to treat these diseases.
In summary, Linda R. Mileshkin is a dedicated and skilled medical professional who specializes in treating various types of cancer. She values communication, teamwork, and staying updated with the latest research to provide the best care possible for her patients. Her work has made a positive impact on many lives, and her commitment to advancing medical knowledge through research is commendable.
Enrollment Status: Completed
Published: October 23, 2023
Intervention Type: Drug
Study Drug: Bintrafusp Alfa
Study Phase: Phase 2
